This transcript provides a detailed pathology discussion focusing on a case of Pleomorphic Liposarcoma (PLS) exhibiting a less common sheet-like epithelioid morphology. The speaker emphasizes the critical diagnostic criterion for PLS: the mandatory presence of at least one pleomorphic lipoblast, which differentiates it from Undifferentiated Pleomorphic Sarcoma (UPS). Although PLS is rare (5% of liposarcomas) and highly aggressive (50% five-year survival), the speaker notes that its treatment, like that of other high-grade adult sarcomas, currently relies on wide local excision and radiation. A significant portion of the discussion is dedicated to distinguishing PLS from Differentiated Liposarcoma (D-diff LS), particularly in complicated cases where D-diff LS exhibits homologous lipoblastic differentiation. The crucial role of MDM2 immunohistochemistry—negative in PLS, positive in D-diff LS—is highlighted for accurate diagnosis, especially when location (extremity vs. retroperitoneum) is ambiguous.
Pleomorphic Liposarcoma (PLS): Identification and Differential Diagnosis
0:03 Case Introduction: The speaker introduces a cellular neoplasm with necrosis, noting the "Dr. Rowe beginner rule" that such findings are malignant 99.9% of the time. The case is identified as Pleomorphic Liposarcoma (PLS).
0:30 Key Diagnostic Feature: PLS is characterized by multi-loculated, multi-vacuolated pleomorphic lipoblasts of varying sizes. These cells often have round, abundant, frothy cytoplasm, and the vacuoles "dent" the nucleus.
1:02 Mandatory Diagnostic Criterion: PLS is the only liposarcoma that requires the presence of at least one pleomorphic lipoblast to meet diagnostic criteria. Without this finding, the diagnosis defaults to High Grade Sarcoma (Undifferentiated Pleomorphic Sarcoma or UPS).
1:32 Morphological Variability: PLS generally presents in two main patterns: the more familiar cellular spindle cell/polymorphic pattern, or sheets of epithelioid cells (as shown in this example). This epithelioid pattern can be confused with other tumors, such as adrenocortical carcinoma.
2:44 Rarity: PLS is the rarest of the main subtypes of liposarcoma, accounting for only about 5% of cases.
3:16 Nuclear Characteristics: PLS often displays extremely bizarre, large, and pleomorphic nuclei, prompting pathologists to "hunt extra hard" for lipoblasts when unusual nuclear features are present.
3:57 Clinical Takeaway (Treatment): For most high-grade adult sarcomas, including PLS and UPS, the treatment is essentially the same (wide local excision and radiation). The speaker suggests that the detailed subtyping of these high-grade tumors is currently more of an academic exercise than one that changes actionable patient treatment.
5:33 Prognosis: PLS is aggressive, with about a 50% five-year survival rate. It typically metastasizes to the lungs within the first five years.
6:04 Location as a Clue: Sarcomas arising in the extremities with lipoblasts are almost certainly PLS. Differentiated Liposarcoma (D-diff LS) most commonly arises in the retroperitoneum.
6:21 Differentiating PLS from D-diff LS: The key difference lies in immunohistochemistry: PLS is almost always MDM2 negative, whereas D-diff LS is almost always MDM2 positive.
7:39 Diagnostic Caveat (Lipoblasts in D-diff): Historically, lipoblasts meant PLS. However, a subset of D-diff LS cases (around 10-20%) can also acquire lipoblasts ("homologous lipoblastic differentiation"), making MDM2 necessary for definitive diagnosis, especially in retroperitoneal locations where PLS rarely occurs.